Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Preventing depression in the community by voluntary sector providers (PERSUADE): intervention development and protocol for a parallel randomised controlled feasibility trial.

Kenning C, Blakemore A, Bower P, Safari M, Cuijpers P, Brown JS, Hann M, Lidbetter N, Muñoz RF, Waheed W.

BMJ Open. 2019 Oct 3;9(10):e023791. doi: 10.1136/bmjopen-2018-023791.

2.

Organisational factors associated with safety climate, patient satisfaction and self-reported medicines adherence in English community pharmacies.

Jacobs S, Hann M, Bradley F, Elvey R, Fegan T, Halsall D, Hassell K, Wagner A, Schafheutle EI.

Res Social Adm Pharm. 2019 Sep 18. pii: S1551-7411(19)30027-0. doi: 10.1016/j.sapharm.2019.09.058. [Epub ahead of print]

3.

Satisfaction with a digitally-enabled telephone health coaching intervention for people with non-diabetic hyperglycaemia.

Coventry P, Bower P, Blakemore A, Baker E, Hann M, Li J, Paisley A, Gibson M.

NPJ Digit Med. 2019 Feb 4;2:5. doi: 10.1038/s41746-019-0080-6. eCollection 2019.

4.

Feasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE-Cog Field Trial.

Hooper E, Simkin Z, Abrams H, Camacho E, Charalambous AP, Collin F, Constantinidou F, Dawes P, Elliott R, Falkingham S, Frison E, Hann M, Helmer C, Himmelsbach I, Hussain H, Marié S, Montecelo S, Reeves D, Regan J, Thodi C, Wolski L, Leroi I.

J Am Geriatr Soc. 2019 Jul;67(7):1472-1477. doi: 10.1111/jgs.15936. Epub 2019 Apr 29.

PMID:
31034588
5.

A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis.

Bhargava R, Kalra PA, Hann M, Brenchley P, Hurst H, Hutchison AJ.

BMC Nephrol. 2019 Feb 4;20(1):37. doi: 10.1186/s12882-019-1216-2.

6.

Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial.

Regan J, Frison E, Collin F, Dawes P, Hann M, Himmelsbach I, Hooper E, Reeves D, Simkin Z, Thodi C, Yang F, Leroi I; SENSE-Cog Trial Development Team.

Trials. 2019 Jan 25;20(1):80. doi: 10.1186/s13063-018-2973-0.

7.

Behavior Change Techniques Associated With Changes in Postintervention and Maintained Changes in Self-Efficacy For Physical Activity: A Systematic Review With Meta-analysis.

Tang MY, Smith DM, Mc Sharry J, Hann M, French DP.

Ann Behav Med. 2019 Aug 16;53(9):801-815. doi: 10.1093/abm/kay090.

PMID:
30534971
8.

The growth of assisted reproductive treatment-conceived children from birth to 5 years: a national cohort study.

Hann M, Roberts SA, D'Souza SW, Clayton P, Macklon N, Brison DR.

BMC Med. 2018 Nov 28;16(1):224. doi: 10.1186/s12916-018-1203-7.

9.

Systemic Sarcoidosis Presenting with Renal Involvement Caused by Various Sarcoidosis-associated Pathophysiological Conditions.

Ueda S, Murakami T, Ogino H, Matsuura M, Tamaki M, Kishi S, Hann M, Toyoda Y, Nagai K, Bando Y, Abe H, Nishioka Y, Doi T.

Intern Med. 2019 Mar 1;58(5):679-684. doi: 10.2169/internalmedicine.1558-18. Epub 2018 Nov 19.

10.

Aging in Skin of Color: Disruption to Elastic Fiber Organization Is Detrimental to Skin's Biomechanical Function.

Langton AK, Alessi S, Hann M, Chien AL, Kang S, Griffiths CEM, Watson REB.

J Invest Dermatol. 2019 Apr;139(4):779-788. doi: 10.1016/j.jid.2018.10.026. Epub 2018 Nov 4.

11.

Novel Chest Wall Reconstruction Following Excision of an Xiphisternal Chondrosarcoma.

Hann MC, Pettiford B, Babycos C.

Ochsner J. 2018 Summer;18(2):180-182. doi: 10.31486/toj.17.0066.

12.

How do organisational configuration and context influence the quantity and quality of NHS services provided by English community pharmacies? A qualitative investigation.

Jacobs S, Fegan T, Bradley F, Halsall D, Hann M, Schafheutle EI.

PLoS One. 2018 Sep 20;13(9):e0204304. doi: 10.1371/journal.pone.0204304. eCollection 2018.

13.

Improving care for older people with long-term conditions and social care needs in Salford: the CLASSIC mixed-methods study, including RCT.

Bower P, Reeves D, Sutton M, Lovell K, Blakemore A, Hann M, Howells K, Meacock R, Munford L, Panagioti M, Parkinson B, Riste L, Sidaway M, Lau YS, Warwick-Giles L, Ainsworth J, Blakeman T, Boaden R, Buchan I, Campbell S, Coventry P, Reilly S, Sanders C, Skevington S, Waheed W, Checkland K.

Southampton (UK): NIHR Journals Library; 2018 Aug.

14.

Approaches to target tractability assessment - a practical perspective.

Brown KK, Hann MM, Lakdawala AS, Santos R, Thomas PJ, Todd K.

Medchemcomm. 2018 Feb 14;9(4):606-613. doi: 10.1039/c7md00633k. eCollection 2018 Apr 1. Review.

15.

Designing and Implementing a Home-Based Couple Management Guide for Couples Where One Partner has Dementia (DemPower): Protocol for a Nonrandomized Feasibility Trial.

Lasrado R, Bielsten T, Hann M, Davies L, Schumm J, Reilly S, Swarbrick C, Keady J, Hellström I.

JMIR Res Protoc. 2018 Aug 10;7(8):e171. doi: 10.2196/resprot.9087.

16.

Early interventions in a US military FIRST episode psychosis program.

Hann MC, Caporaso E, Loeffler G, Cuellar A, Herrington L, Marrone L, Yoon J.

Early Interv Psychiatry. 2018 Dec;12(6):1243-1249. doi: 10.1111/eip.12709. Epub 2018 Jul 3.

PMID:
29971958
17.

Is telephone health coaching a useful population health strategy for supporting older people with multimorbidity? An evaluation of reach, effectiveness and cost-effectiveness using a 'trial within a cohort'.

Panagioti M, Reeves D, Meacock R, Parkinson B, Lovell K, Hann M, Howells K, Blakemore A, Riste L, Coventry P, Blakeman T, Sidaway M, Bower P.

BMC Med. 2018 May 30;16(1):80. doi: 10.1186/s12916-018-1051-5.

18.

Long-term clinical and cost-effectiveness of collaborative care (versus usual care) for people with mental-physical multimorbidity: cluster-randomised trial.

Camacho EM, Davies LM, Hann M, Small N, Bower P, Chew-Graham C, Baguely C, Gask L, Dickens CM, Lovell K, Waheed W, Gibbons CJ, Coventry P.

Br J Psychiatry. 2018 Aug;213(2):456-463. doi: 10.1192/bjp.2018.70. Epub 2018 May 15.

19.

Progressive renal insufficiency related to ALK inhibitor, alectinib.

Nagai K, Ono H, Matsuura M, Hann M, Ueda S, Yoshimoto S, Tamaki M, Murakami T, Abe H, Ishikura H, Doi T.

Oxf Med Case Reports. 2018 Apr 25;2018(4):omy009. doi: 10.1093/omcr/omy009. eCollection 2018 Apr.

20.

Developing a core outcome set for people living with dementia at home in their neighbourhoods and communities: study protocol for use in the evaluation of non-pharmacological community-based health and social care interventions.

Harding AJE, Morbey H, Ahmed F, Opdebeeck C, Wang YY, Williamson P, Swarbrick C, Leroi I, Challis D, Davies L, Reeves D, Holland F, Hann M, Hellström I, Hydén LC, Burns A, Keady J, Reilly S.

Trials. 2018 Apr 24;19(1):247. doi: 10.1186/s13063-018-2584-9.

21.

Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences.

Infante Lara L, Fenner S, Ratcliffe S, Isidro-Llobet A, Hann M, Bax B, Osheroff N.

Nucleic Acids Res. 2018 Mar 16;46(5):2218-2233. doi: 10.1093/nar/gky072.

22.

Collaborative case management to aid return to work after long-term sickness absence: a pilot randomised controlled trial.

Kenning C, Lovell K, Hann M, Agius R, Bee PE, Chew-Graham C, Coventry PA, van der Feltz-Cornelis CM, Gilbody S, Hardy G, Kellett S, Kessler D, McMillan D, Reeves D, Rick J, Sutton M, Bower P.

Southampton (UK): NIHR Journals Library; 2018 Jan.

23.

Effect of health literacy on the quality of life of older patients with long-term conditions: a large cohort study in UK general practice.

Panagioti M, Skevington SM, Hann M, Howells K, Blakemore A, Reeves D, Bower P.

Qual Life Res. 2018 May;27(5):1257-1268. doi: 10.1007/s11136-017-1775-2. Epub 2018 Jan 10.

24.

The cohort multiple randomized controlled trial design was found to be highly susceptible to low statistical power and internal validity biases.

Reeves D, Howells K, Sidaway M, Blakemore A, Hann M, Panagioti M, Bower P.

J Clin Epidemiol. 2018 Mar;95:111-119. doi: 10.1016/j.jclinepi.2017.12.008. Epub 2017 Dec 19.

25.

Improving hearing and vision in dementia: protocol for a field trial of a new intervention.

Regan J, Dawes P, Pye A, Armitage CJ, Hann M, Himmelsbach I, Reeves D, Simkin Z, Yang F, Leroi I.

BMJ Open. 2017 Nov 28;7(11):e018744. doi: 10.1136/bmjopen-2017-018744.

26.

Investigating the organisational factors associated with variation in clinical productivity in community pharmacies: a mixed-methods study.

Jacobs S, Bradley F, Elvey R, Fegan T, Halsall D, Hann M, Hassell K, Wagner A, Schafheutle E.

Southampton (UK): NIHR Journals Library; 2017 Oct.

27.

Recurrent Pneumothoraces in a Patient With Pulmonary Benign Metastasizing Leiomyoma.

Hann M, Manacheril R, St Pierre J, Gala R.

Ochsner J. 2017 Fall;17(3):284-287.

28.

Organisational and extraorganisational determinants of volume of service delivery by English community pharmacies: a cross-sectional survey and secondary data analysis.

Hann M, Schafheutle EI, Bradley F, Elvey R, Wagner A, Halsall D, Hassell K, Jacobs S.

BMJ Open. 2017 Oct 10;7(10):e017843. doi: 10.1136/bmjopen-2017-017843.

29.

Modulators of 14-3-3 Protein-Protein Interactions.

Stevers LM, Sijbesma E, Botta M, MacKintosh C, Obsil T, Landrieu I, Cau Y, Wilson AJ, Karawajczyk A, Eickhoff J, Davis J, Hann M, O'Mahony G, Doveston RG, Brunsveld L, Ottmann C.

J Med Chem. 2018 May 10;61(9):3755-3778. doi: 10.1021/acs.jmedchem.7b00574. Epub 2017 Oct 19. Review.

31.

What is the future for fragment-based drug discovery?

Keserű GM, Hann MM.

Future Med Chem. 2017 Sep;9(13):1457-1460. doi: 10.4155/fmc-2017-0106. Epub 2017 Aug 10. No abstract available.

PMID:
28795595
32.

Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery.

Mateus A, Gordon LJ, Wayne GJ, Almqvist H, Axelsson H, Seashore-Ludlow B, Treyer A, Matsson P, Lundbäck T, West A, Hann MM, Artursson P.

Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6231-E6239. doi: 10.1073/pnas.1701848114. Epub 2017 Jul 12.

33.

Stabilization of protein-protein interactions in drug discovery.

Andrei SA, Sijbesma E, Hann M, Davis J, O'Mahony G, Perry MWD, Karawajczyk A, Eickhoff J, Brunsveld L, Doveston RG, Milroy LG, Ottmann C.

Expert Opin Drug Discov. 2017 Sep;12(9):925-940. doi: 10.1080/17460441.2017.1346608. Epub 2017 Jul 11. Review.

PMID:
28695752
34.

Bioethics in Practice: Ethical Issues in the Care of Transgender Patients.

Hann M, Ivester R, Denton GD.

Ochsner J. 2017 Summer;17(2):144-145. No abstract available.

35.

Patient-reported safety incidents in older patients with long-term conditions: a large cross-sectional study.

Panagioti M, Blakeman T, Hann M, Bower P.

BMJ Open. 2017 May 30;7(5):e013524. doi: 10.1136/bmjopen-2016-013524.

36.

Predicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) Study.

Nasir JM, Pomeroy W, Marler A, Hann M, Baykaner T, Jones R, Stoll R, Hursey K, Meadows A, Walker J, Kindsvater S.

Heart Rhythm. 2017 Jul;14(7):955-961. doi: 10.1016/j.hrthm.2017.04.026. Epub 2017 May 12.

PMID:
28506913
37.

Wave energy absorption by a submerged air bag connected to a rigid float.

Kurniawan A, Chaplin JR, Hann MR, Greaves DM, Farley FJM.

Proc Math Phys Eng Sci. 2017 Apr;473(2200):20160861. doi: 10.1098/rspa.2016.0861. Epub 2017 Apr 5.

38.

The Patient Assessment of Chronic Illness Care produces measurements along a single dimension: results from a Mokken analysis.

Gibbons CJ, Small N, Rick J, Burt J, Hann M, Bower P.

Health Qual Life Outcomes. 2017 Apr 4;15(1):61. doi: 10.1186/s12955-017-0638-4.

39.

Influential factors on serum albumin concentration in hospitalized chronic kidney disease patients.

Yoshimoto S, Nagai K, Shibata E, Ueda S, Ono H, Tamaki M, Nishimura K, Obata F, Inagaki T, Minato M, Kishi F, Matsuura M, Matsui N, Endo I, Hann M, Kishi S, Murakami T, Abe H, Doi T.

J Med Invest. 2017;64(1.2):146-152. doi: 10.2152/jmi.64.146.

40.

The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis.

Liddle J, Beaufils B, Binnie M, Bouillot A, Denis AA, Hann MM, Haslam CP, Holmes DS, Hutchinson JP, Kranz M, McBride A, Mirguet O, Mole DJ, Mowat CG, Pal S, Rowland P, Trottet L, Uings IJ, Walker AL, Webster SP.

Bioorg Med Chem Lett. 2017 May 1;27(9):2023-2028. doi: 10.1016/j.bmcl.2017.02.078. Epub 2017 Mar 9.

41.

The impact of advertising patient and public involvement on trial recruitment: embedded cluster randomised recruitment trial.

Hughes-Morley A, Hann M, Fraser C, Meade O, Lovell K, Young B, Roberts C, Cree L, More D, O'Leary N, Callaghan P, Waheed W, Bower P.

Trials. 2016 Dec 8;17(1):586.

42.

Patient activation in older people with long-term conditions and multimorbidity: correlates and change in a cohort study in the United Kingdom.

Blakemore A, Hann M, Howells K, Panagioti M, Sidaway M, Reeves D, Bower P.

BMC Health Serv Res. 2016 Oct 18;16(1):582.

43.

The individual contribution and relative importance of self-management and quality of care on glycaemic control in type 2 diabetes.

Martínez YV, Campbell SM, Hann M, Bower P.

Salud Publica Mex. 2016 Aug;58(4):404-11.

PMID:
27599072
44.

Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboration (CATFISH): study protocol for a randomized controlled trial.

Coventry PA, Bower P, Blakemore A, Baker L, Hann M, Paisley A, Renwick C, Li J, Ugajin A, Gibson M.

Trials. 2016 Aug 26;17(1):424. doi: 10.1186/s13063-016-1519-6.

45.

Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia.

Keserű GM, Erlanson DA, Ferenczy GG, Hann MM, Murray CW, Pickett SD.

J Med Chem. 2016 Sep 22;59(18):8189-206. doi: 10.1021/acs.jmedchem.6b00197. Epub 2016 May 16.

PMID:
27124799
46.

International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids.

Loeffler G, Delaney E, Hann M.

Brain Res Bull. 2016 Sep;126(Pt 1):8-28. doi: 10.1016/j.brainresbull.2016.04.013. Epub 2016 Apr 21. Review.

PMID:
27108542
47.

The effect of albumin leakage in hemodialysis patients on redox status of serum albumin.

Nagai K, Tsuchida K, Hirose D, Michiwaki H, Hann M, Kanayama HO, Doi T, Minakuchi J.

J Artif Organs. 2016 Sep;19(3):310-4. doi: 10.1007/s10047-016-0900-2. Epub 2016 Apr 16.

PMID:
27086124
48.

Evaluating a complex model designed to increase access to high quality primary mental health care for under-served groups: a multi-method study.

Dowrick C, Bower P, Chew-Graham C, Lovell K, Edwards S, Lamb J, Bristow K, Gabbay M, Burroughs H, Beatty S, Waheed W, Hann M, Gask L.

BMC Health Serv Res. 2016 Feb 17;16:58. doi: 10.1186/s12913-016-1298-5.

49.

Factors affecting embryo viability and uterine receptivity: insights from an analysis of the UK registry data.

Roberts SA, Hann M, Brison DR.

Reprod Biomed Online. 2016 Feb;32(2):197-206. doi: 10.1016/j.rbmo.2015.11.002. Epub 2015 Nov 11.

PMID:
26655652
50.

Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin.

Chan PF, Srikannathasan V, Huang J, Cui H, Fosberry AP, Gu M, Hann MM, Hibbs M, Homes P, Ingraham K, Pizzollo J, Shen C, Shillings AJ, Spitzfaden CE, Tanner R, Theobald AJ, Stavenger RA, Bax BD, Gwynn MN.

Nat Commun. 2015 Dec 7;6:10048. doi: 10.1038/ncomms10048.

Supplemental Content

Support Center